Oakworth Capital’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $319K | Hold |
1,111
| – | – | 0.02% | 161 |
|
|
2025
Q1 | $342K | Hold |
1,111
| – | – | 0.02% | 153 |
|
|
2024
Q4 | $392K | Hold |
1,111
| – | – | 0.03% | 145 |
|
|
2024
Q3 | $398K | Hold |
1,111
| – | – | 0.03% | 142 |
|
|
2024
Q2 | $354K | Hold |
1,111
| – | – | 0.03% | 141 |
|
|
2024
Q1 | $255K | Hold |
1,111
| – | – | 0.02% | 173 |
|
|
2023
Q4 | $244K | Hold |
1,111
| – | – | 0.02% | 169 |
|
|
2023
Q3 | $251K | Hold |
1,111
| – | – | 0.02% | 147 |
|
|
2023
Q2 | $245K | Hold |
1,111
| – | – | 0.02% | 152 |
|
|
2023
Q1 | $249K | Hold |
1,111
| – | – | 0.02% | 147 |
|
|
2022
Q4 | $309K | Hold |
1,111
| – | – | 0.03% | 124 |
|
|
2022
Q3 | $233K | Hold |
1,111
| – | – | 0.03% | 144 |
|
|
2022
Q2 | $262K | Buy |
+1,111
| New | +$262K | 0.03% | 143 |
|
|
2018
Q1 | – | Sell |
-64
| Closed | -$8K | – | 649 |
|
|
2017
Q4 | $8K | Sell |
64
-445
| -87% | -$55.6K | ﹤0.01% | 479 |
|
|
2017
Q3 | $67K | Sell |
509
-224
| -31% | -$29.5K | 0.02% | 263 |
|
|
2017
Q2 | $95K | Sell |
733
-123
| -14% | -$15.9K | 0.03% | 224 |
|
|
2017
Q1 | $116K | Hold |
856
| – | – | 0.03% | 204 |
|
|
2016
Q4 | $107K | Hold |
856
| – | – | 0.04% | 204 |
|
|
2016
Q3 | $102K | Sell |
856
-287
| -25% | -$34.2K | 0.04% | 193 |
|
|
2016
Q2 | $136K | Hold |
1,143
| – | – | 0.05% | 176 |
|
|
2016
Q1 | $128K | Buy |
+1,143
| New | +$128K | 0.05% | 156 |
|